Liolis Gateway September 2018 Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

Appointment of Executive Officer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported)   September 4, 2018   REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter)   New … Continued

CEO, Andy Sealfon, discusses RMS company updates and other exciting news

Join Andy Sealfon as he discusses recent happenings at RMS on the Princeton Research Radio Show. Andy talks about various international updates including the International Distributor meeting that took place in Berlin in early June and shares some great feedback from the ongoing clinical trials in Russia with a pharmaceutical company.  He also discusses RMS’ … Continued

June 2018 Investor Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market and the Company’s compounded annual growth rate (CAGR). Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or contribute … Continued

RMS to Present at the 8th Annual LD Micro Invitational Conference

Chester, NY / May 23, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Lead Independent Director Dan Goldberger will be presenting at the 8th annual LD Micro Invitational Conference taking place June 4-6, 2018 at the Luxe Sunset hotel in Bel-Air, California.   The Company’s presentation will take … Continued

RMS April 23, 2018 Annual Shareholder Meeting Presentation

2017 Breakthrough Year Highlights Highest Reported Twelve Month Net Sales and Net Income in RMS History 25% Increase in Net Sales 21% Increase in Gross Profit 12% Decrease in Operating Expenses as % of Net Sales 7% Increase in Net Income as % of Net Sales

Daniel Goldberger Nominated for Election to RMS Board of Directors

CHESTER, NY / March 14, 2018 / The Board of Directors of Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that seasoned senior executive and business leader Daniel Goldberger has been nominated to stand for election to the board at the Company’s Annual Meeting of Shareholders on April 23, 2018, replacing … Continued